Geneva Capital Management LLC trimmed its position in shares of Option Care Health, Inc. (NASDAQ:OPCH – Free Report) by 34.2% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 719,391 shares of the company’s stock after selling 374,550 shares during the period. Geneva Capital Management LLC’s holdings in Option Care Health were worth $16,179,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently modified their holdings of the company. Dimensional Fund Advisors LP increased its holdings in Option Care Health by 0.9% in the first quarter. Dimensional Fund Advisors LP now owns 3,876,856 shares of the company’s stock valued at $104,368,000 after buying an additional 36,208 shares during the last quarter. Southpoint Capital Advisors LP lifted its holdings in Option Care Health by 20.0% during the 1st quarter. Southpoint Capital Advisors LP now owns 3,600,000 shares of the company’s stock worth $96,912,000 after buying an additional 600,000 shares during the last quarter. Van Berkom & Associates Inc. grew its position in shares of Option Care Health by 18.2% in the 3rd quarter. Van Berkom & Associates Inc. now owns 2,583,253 shares of the company’s stock worth $58,097,000 after acquiring an additional 397,369 shares in the last quarter. Bank of America Corp DE grew its position in shares of Option Care Health by 14.6% in the 1st quarter. Bank of America Corp DE now owns 1,945,015 shares of the company’s stock worth $52,360,000 after acquiring an additional 247,766 shares in the last quarter. Finally, The Manufacturers Life Insurance Company increased its holdings in shares of Option Care Health by 2.1% in the 1st quarter. The Manufacturers Life Insurance Company now owns 1,804,871 shares of the company’s stock valued at $48,587,000 after acquiring an additional 36,906 shares during the last quarter. Institutional investors own 98.05% of the company’s stock.
Wall Street Analysts Forecast Growth
Several equities research analysts recently issued reports on OPCH shares. Deutsche Bank lowered Option Care Health from a “buy” rating to a “hold” rating and dropped their price target for the company from $26.00 to $24.00 in a research report on Thursday, July 30th. Weiss Ratings raised shares of Option Care Health from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday, October 20th. Wall Street Zen raised shares of Option Care Health from a “hold” rating to a “buy” rating in a report on Saturday, August 1st. Jefferies Financial Group lowered shares of Option Care Health from a “buy” rating to a “hold” rating and boosted their target price for the company from $28.00 to $32.05 in a research note on Tuesday, October 6th. Finally, UBS Group cut shares of Option Care Health from a “buy” rating to a “neutral” rating and dropped their target price for the stock from $39.00 to $32.05 in a report on Friday, October 9th. Two equities research analysts have rated the stock with a Buy rating and fourteen have given a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $29.48.
Read Our Latest Analysis on OPCH
Option Care Health Price Performance
OPCH stock opened at $31.65 on Monday. The stock has a market cap of $4.74 billion, a PE ratio of 22.77, a price-to-earnings-growth ratio of 1.92 and a beta of 0.47. The firm’s 50-day simple moving average is $28.08 and its 200 day simple moving average is $26.26. Option Care Health, Inc. has a fifty-two week low of $18.01 and a fifty-two week high of $36.80. The company has a quick ratio of 1.06, a current ratio of 1.54 and a debt-to-equity ratio of 0.87.
Option Care Health (NASDAQ:OPCH – Get Free Report) last posted its earnings results on Wednesday, November 4th. The company reported $0.49 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.49. Option Care Health had a net margin of 3.74% and a return on equity of 19.06%. The firm had revenue of $1.49 billion during the quarter, compared to analyst estimates of $1.48 billion. During the same period in the previous year, the business posted $0.45 EPS. Option Care Health’s revenue was up 4.1% on a year-over-year basis. As a group, sell-side analysts predict that Option Care Health, Inc. will post 1.70 EPS for the current year.
Option Care Health Company Profile
Option Care Health, Inc. is a U.S. provider of home and alternate-site infusion therapy services. The company coordinates infusion care for patients who need medications or nutritional support administered outside a hospital, including in their homes or at infusion centers. Its services include specialty pharmacy, nursing, care coordination and clinical support. Option Care Health provides therapies for a range of acute and chronic conditions, including immune disorders, infections, bleeding disorders and nutritional needs.
Featured Articles
- Five stocks we like better than Option Care Health
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Want to see what other hedge funds are holding OPCH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Option Care Health, Inc. (NASDAQ:OPCH – Free Report).
Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.
